
THERMO FISHER SCIENT. CDR
Share · CA88355G1000 · A404RW (XFRA)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of THERMO FISHER SCIENT. CDR
No Price
29.04.2026 05:27
Current Prices from THERMO FISHER SCIENT. CDR
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
Quotrix |
TFSIRS00.DUSD
|
EUR
|
29.04.2026 05:27
|
10,60 EUR
| 0,40 EUR
+3,92 %
|
Düsseldorf |
TFSIRS00.DUSB
|
EUR
|
28.04.2026 17:31
|
10,10 EUR
| -0,10 EUR
-0,98 %
|
Company Profile for THERMO FISHER SCIENT. CDR Share
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Company Data
Name THERMO FISHER SCIENT. CDR
Company Thermo Fisher Scientific Inc.
Website
https://www.thermofisher.com
Primary Exchange
Frankfurt
Frankfurt
WKN A404RW
ISIN CA88355G1000
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Marc N. Casper
Market Capitalization 292 Mrd.
Country United States of America
Currency EUR
Employees 125,0 T
Address 168 Third Avenue, 02451 Waltham
IPO Date 2024-02-15
Dividends from 'THERMO FISHER SCIENT. CDR'
| Ex-Date | Dividend per Share |
|---|---|
| 15.09.2025 | 0,02 CAD |
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | TFSIRS00.DUSB |
| Frankfurt | TN80.F |
| Quotrix | TFSIRS00.DUSD |
More Shares
Investors who hold THERMO FISHER SCIENT. CDR also have the following shares in their portfolio:
